Antioxidant action of xanthine oxidase inhibitor febuxostat protects the liver and blood vasculature in SHRSP5/Dmcr rats
Authors:
Open Access
- 27 June 2023
- journal article
- research article
- Published by University of South Bohemia in Ceske Budejovice in Journal of Applied Biomedicine
- Vol. 21 (2) , 80-90
Abstract
Xanthine oxidase (XO) generates reactive oxygen species during uric acid production. Therefore, XO inhibitors, which suppress oxidative stress, may effectively treat non-alcoholic steatohepatitis (NASH) and atherosclerosis via uric acid reduction. In this study, we examined the antioxidant effect of the XO inhibitor febuxostat on NASH and atherosclerosis in stroke-prone spontaneously hypertensive 5 (SHRSP5/Dmcr) rats. SHRSP5/Dmcr rats were divided into three groups: SHRSP5/Dmcr + high-fat and high-cholesterol (HFC) diet [control group, n = 5], SHRSP5/Dmcr + HFC diet + 10% fructose (40 ml/day) [fructose group, n = 5], and SHRSP5/Dmcr + HFC diet + 10% fructose (40 ml/day) + febuxostat (1.0 mg/kg/day) [febuxostat group, n = 5]. Glucose and insulin resistance, blood biochemistry, histopathological staining, endothelial function, and oxidative stress markers were evaluated. Febuxostat reduced the plasma uric acid levels. Oxidative stress-related genes were downregulated, whereas antioxidant factor-related genes were upregulated in the febuxostat group compared with those in the fructose group. Febuxostat also ameliorated inflammation, fibrosis, and lipid accumulation in the liver. Mesenteric lipid deposition decreased in the arteries, and aortic endothelial function improved in the febuxostat group. Overall, the XO inhibitor febuxostat exerted protective effects against NASH and atherosclerosis in SHRSP5/Dmcr rats.Keywords
This publication has 44 references indexed in Scilit:
- Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/DmcrEnvironmental Health and Preventive Medicine, 2011
- Febuxostat inhibition of endothelial-bound XO: Implications for targeting vascular ROS productionFree Radical Biology and Medicine, 2011
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Effects of Teucrium polium on Insulin Resistance in Nonalcoholic SteatohepatitisJournal of Acupuncture and Meridian Studies, 2010
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes MellitusDiabetes, 2009
- Uric Acid and Cardiovascular RiskNew England Journal of Medicine, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential HypertensionHypertension, 2000
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995